Xtant Medical (NASDAQ: XTNT) CEO now tied to 1.72M unvested shares
Rhea-AI Filing Summary
Xtant Medical Holdings, Inc. reported that President and CEO Sean E. Browne received a grant of 550,000 shares of Common Stock in the form of deferred stock units under the Amended and Restated 2023 Equity Incentive Plan. These DSUs will vest in four equal installments of 137,500 shares on each of August 15, 2027, 2028, 2029, and 2030, conditioned on his continued employment, with settlement of vested shares deferred to a later date. A separate transaction shows 10,605 shares of Common Stock withheld at $0.31 per share to satisfy tax withholding obligations upon vesting and settlement of existing restricted stock unit awards. Footnote disclosure states that Browne has an aggregate of 1,720,123 shares issuable upon vesting and settlement of RSU and DSU awards, subject to future service-based vesting.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 539,395 shares
Net Buy
2 txns
Insider
Browne Sean E
Role
President and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1, F2 | 550,000 | $0.00 | $0.00 |
| Tax Withholding | Common Stock F3, F2 | 10,605 | $0.31 | $3K |
Holdings After Transaction:
Common Stock — 3,114,669 shares (Direct)
Footnotes (3)
- F1. These shares will vest with respect to 137,500 shares on each of August 15, 2027, August 15, 2028, August 15, 2029 and August 15, 2030 pursuant to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock.
- F2. Includes an aggregate of 1,720,123 shares issuable upon vesting and settlement of restricted stock unit awards or DSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates.
- F3. These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.
Key Figures
DSU grant: 550,000 shares
Annual DSU vesting tranche: 137,500 shares
Tax withholding shares: 10,605 shares
+2 more
5 metrics
DSU grant
550,000 shares
Deferred stock unit award of Common Stock granted to CEO on August 15, 2026
Annual DSU vesting tranche
137,500 shares
Portion of DSU grant vesting on each of August 15, 2027, 2028, 2029 and 2030
Tax withholding shares
10,605 shares
Shares withheld to satisfy tax withholding obligations on RSU vesting
Tax withholding price
$0.31 per share
Per-share value used for shares withheld for tax obligations
Aggregate unvested RSU/DSU shares
1,720,123 shares
Shares issuable to CEO upon future vesting and settlement of RSU and DSU awards
Key Terms
deferred stock unit, restricted stock unit, tax withholding obligations, Equity Incentive Plan
4 terms
deferred stock unit financial
"pursuant to a deferred stock unit (DSU) award granted under the Xtant Medical"
A deferred stock unit (DSU) is a promise from a company to give an employee or director the value of a share at a future date, paid in actual shares or cash when certain conditions are met (such as retirement or a set date). Think of it like a gift card that converts to company stock later; it aligns pay with long‑term performance and can affect future share count, compensation expense and potential cash needs, so investors watch DSUs for their impact on dilution and company finances.
restricted stock unit financial
"shares issuable upon vesting and settlement of restricted stock unit awards or DSU"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
tax withholding obligations financial
"shares were withheld by the Issuer to pay tax withholding obligations upon vesting"
Equity Incentive Plan financial
"Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
FAQ
What equity award did XTNT grant to CEO Sean E. Browne on August 15, 2026?
Sean E. Browne received a grant of 550,000 deferred stock units (DSUs) of XTNT Common Stock. These DSUs vest in four equal tranches of 137,500 shares each on August 15 of 2027, 2028, 2029, and 2030, subject to continued employment.
How do the newly granted XTNT DSUs to the CEO vest over time?
The 550,000 XTNT DSUs vest in four equal installments of 137,500 shares each. Vesting dates are August 15, 2027, 2028, 2029, and 2030, and each installment requires that Sean E. Browne remain an employee through the applicable vesting date.
Does the XTNT CEO’s new DSU award settle immediately upon vesting?
No. While each DSU vests on scheduled dates, settlement of the vested shares is deferred. The vested DSUs will be settled into XTNT Common Stock at a later date, in accordance with the specific terms of the DSU award agreement.
AI-generated analysis. How Rhea-AI works. Not financial advice.
